Values First Advisors Inc. Acquires 845 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Values First Advisors Inc. raised its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 46.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,671 shares of the exchange traded fund’s stock after purchasing an additional 845 shares during the period. Values First Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $238,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Farther Finance Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 26.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 630 shares of the exchange traded fund’s stock valued at $52,000 after purchasing an additional 130 shares during the last quarter. James J. Burns & Company LLC raised its holdings in shares of SPDR S&P Biotech ETF by 5.0% in the third quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after purchasing an additional 146 shares during the last quarter. Integrated Wealth Concepts LLC raised its holdings in shares of SPDR S&P Biotech ETF by 0.7% in the second quarter. Integrated Wealth Concepts LLC now owns 21,635 shares of the exchange traded fund’s stock valued at $1,800,000 after purchasing an additional 155 shares during the last quarter. Ancora Advisors LLC raised its holdings in shares of SPDR S&P Biotech ETF by 47.9% in the first quarter. Ancora Advisors LLC now owns 491 shares of the exchange traded fund’s stock valued at $67,000 after purchasing an additional 159 shares during the last quarter. Finally, Moser Wealth Advisors LLC increased its holdings in SPDR S&P Biotech ETF by 10.4% during the third quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock worth $149,000 after buying an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.0 %

NYSEARCA XBI traded down $0.02 during trading hours on Thursday, reaching $94.89. 10,197,612 shares of the company were exchanged, compared to its average volume of 11,771,370. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The business’s 50 day simple moving average is $93.27 and its 200-day simple moving average is $82.57. The stock has a market capitalization of $7.28 billion, a P/E ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.